Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling

Arteriosclerosis, Thrombosis, and Vascular Biology
Xin ZhaoStephen F Vatner

Abstract

Stimulation of cardiac α1A-adrenergic receptors (α1A-AR) has been proposed for treatment of heart failure, since it increases myocardial contractility. We investigated a different mechanism, induction of angiogenesis. Four to 6 weeks after permanent coronary artery occlusion, transgenic rats with cardiomyocyte-specific α1A-adrenergic receptor overexpression had less remodeling than their nontransgenic littermates, with less fibrosis, hypertrophy and lung weight, and preserved left ventricular ejection fraction and wall stress (all P<0.05). Coronary blood flow, measured with microspheres, increased in the infarct zone in transgenic rats compared with nontransgenic littermates (1.4±0.2 versus 0.5±0.08 mL min(-1) g(-1); P<0.05), which is consistent with angiogenesis, as reflected by a 20% increase in capillary density in the zone adjacent to the infarct. The question arose, how does transgenic overexpression of a gene in cardiomyocytes induce angiogenesis? We identified a paracrine mechanism, whereby vascular endothelial growth factor-A mRNA and protein were increased in isolated transgenic cardiomyocytes and also by nontransgenic littermate cardiomyocytes treated with an α1A-agonist, resulting in angiogenesis. Conditioned medium ...Continue Reading

References

Jul 17, 1998·The New England Journal of Medicine·W WijnsP G Camici
Mar 4, 2000·The New England Journal of Medicine·S H LeeP A Thistlethwaite
Mar 29, 2001·Journal of Molecular and Cellular Cardiology·L XiaoW S Colucci
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·F J GiordanoN Ferrara
Aug 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ivan B LobovRichard A Lang
Dec 24, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Martin N NakatsuChristopher C W Hughes
Dec 24, 2005·Circulation Research·Christophe DepreStephen F Vatner
Aug 15, 2006·European Journal of Pharmacology·Enrique MendezGuillermo Ceballos
Oct 31, 2006·American Heart Journal·Richard Shannon, Mohammad Chaudhry
Dec 22, 2006·Genes & Development·Ichiro Shiojima, Kenneth Walsh
Nov 3, 2007·The Journal of Clinical Investigation·Joerg HeinekeJeffery D Molkentin
Dec 18, 2007·British Journal of Pharmacology·M CiccarelliG Iaccarino
Jun 16, 2009·Congestive Heart Failure·Ramzan M ZakirRobert L Berkowitz
Nov 19, 2009·Circulation. Heart Failure·Brian C JensenPaul C Simpson
Aug 18, 2010·International Journal of Cancer. Journal International Du Cancer·Soon Young ParkHoi Young Lee
Sep 2, 2010·Circulation·Daniela TirziuMichael Simons
Sep 22, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Brian C JensenPaul C Simpson
Dec 2, 2010·Journal of Molecular and Cellular Cardiology·Brian C JensenPaul C Simpson
Feb 7, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Xin ZhaoStephen F Vatner
May 23, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Rebecca Parodi-RullanSabzali Javadov
Jan 2, 2013·Basic Research in Cardiology·Misun ParkDorothy E Vatner
Mar 15, 2013·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Cheng-Wei XuHui-Hua Li
Apr 10, 2014·Cardiovascular Research·Emilio HirschThomas Thum

❮ Previous
Next ❯

Citations

Apr 4, 2017·Journal of Molecular and Cellular Cardiology·John P HeadrickNicolas J C Stapelberg
Mar 14, 2017·JACC. Basic to Translational Science·JuYoun BeakBrian C Jensen
Feb 12, 2019·British Journal of Pharmacology·Ling Yeong ChiaMasaaki Sato
Aug 17, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Takerra K JohnsonDong Liu
Mar 27, 2020·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Koichi NishimuraStephen F Vatner
Apr 4, 2018·Journal of Hypertension·Vishal MaliKhalid Matrougui
Dec 5, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Jiandong ZhangBrian C Jensen
Mar 2, 2021·Journal of Molecular and Cellular Cardiology·Xenia KaidonisRobert M Graham
Jun 12, 2021·Frontiers in Cell and Developmental Biology·Dianne M Perez
Aug 20, 2021·Gene·Raja Ishaq Nabi KhanAshok Kumar Tiwari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.